Log on / register
Feedback | Support | My details

Comments

Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compounds

John C Boik email and Robert A Newman email

BMC Pharmacology 2008, 8:12doi:10.1186/1471-2210-8-12

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.